XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
 3 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash flows from operating activities:    
Net loss $ (2,131,712) $ (3,672,348)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 37,172 27,345
Amortization of debt discounts 238,882 998,076
Amortization of operating right-of-use assets 9,793 8,435
Allowance for credit losses 47,785
Stock-based compensation 439,332
Unrealized holding gain on marketable securities (60,172)
Change in operating assets and liabilities    
Accounts receivable (38,300) (1,092)
Inventories 15,317 66,125
Other receivables and other current assets (154,389) (419,771)
Prepayments (7,302) (256,331)
Accounts payable 92,622 109,607
Accounts payable, related parties (8,789)
Customer deposits (7,786) 19,394
Contract liability 53,848 115,402
Other payables and accrued liabilities 21,841 21,236
Other payables, related parties 2,332 93,330
Operating lease liabilities (9,793) (8,347)
Income tax payables (4,900) 11,500
Net cash used in operating activities (1,894,762) (2,456,896)
Cash flows from investing activities:    
Purchases of equipment (6,234) (34,399)
Net cash used in investing activities (6,234) (34,399)
Cash flows from financing activities:    
Payments of deferred offering cost (15,000)
Proceeds from issuance of common stock in initial public offering 8,235,110
Principal payments of insurance loan (79,556)
Payments of related party loan (1,107) (1,203)
Proceeds from issuance of convertible notes 2,672,092
Repayment of senior note (65,000)
Repayments to related parties (1,621,499)
Proceeds from third party loans 557,549
Repayments to third party loans (1,951,041)
Net cash (used in) provided by financing activities (80,663) 7,811,008
Effects of exchange rate on cash and cash equivalents 4,409 (157,130)
(Decrease) Increase in cash and cash equivalents (1,977,250) 5,162,583
Cash and cash equivalents, beginning of period 4,593,634 1,845,232
Cash and cash equivalents, end of period 2,616,384 7,007,815
Supplemental cash flows information    
Income taxes paid 20,957
Interest paid 1,974 42,998
Supplemental non-cash flows information    
Offering costs paid in the prior period 93,536
Beneficial conversion feature resulted from issuance of convertible notes 537,383
Fair value of warrants issued to underwriter 175,349
Fair value of warrants issued to consultant 856,170
Fair value of common stock issued to consultant 439,332
Recognition of operating right-of-use asset and lease liability 87,704
Conversion of convertible note payable, net of unamortized discounts 1,325,638 14,097,414
Conversion of convertible note payable, related parties 2,437,574
Marketable securities received as a deposit for software developing service $ 1,000,000